Key takeaways:
The 2025-2026 Novavax COVID-19 vaccine, called Nuvaxovid, is FDA approved and recommended for adults and adolescents ages 12 and older. It’s another option to consider alongside the updated Pfizer and Moderna COVID vaccines.
You can search for Novavax vaccines near you by using an online search tool from the manufacturer. Just enter your ZIP code or let the website know what your location is.
If you’re unsure which COVID vaccine to get, talk with a healthcare professional. This year, the CDC recommends making vaccination decisions on an individual basis (rather than following a one-size-fits-all approach).
Save on related medications
The updated Novavax COVID-19 vaccine is one of four COVID vaccines currently available in the U.S. The 2025-2026 version of the vaccine targets a subvariant of the virus called JN.1. All of the vaccines can help prevent severe illness and hospitalization.
Below you’ll find more information about the updated Novavax vaccine, called Nuvaxovid, and where to schedule an appointment near you.
Key facts about Nuvaxovid, the Novavax COVID vaccine
The Novavax COVID vaccine is an adjuvanted, protein-based vaccine that helps prevent COVID. It’s not a mRNA vaccine.
Here’s what you need to know about the 2025-2026 Nuvaxovid vaccine:
In 2025, the FDA and CDC approved and recommended an updated version of Nuvaxovid. People who are at least 12 years old are eligible to receive it. The previous versions of the Novavax vaccine are no longer available.
Nuvaxovid is specifically approved for adults ages 65 and older. It's also approved for people ages 12 to 64 who have at least one health condition that increases their risk of severe COVID, such as asthma or diabetes.
The CDC has no official preference between the updated Pfizer and Moderna COVID vaccines — Comirnaty, Spikevax, and mNEXSPIKE — and Nuvaxovid. If you’re eligible for all four, feel free to receive one that you want. The CDC now advises people to make personalized decisions about their COVID vaccine with a healthcare professional.
You can receive 1 dose of the 2025-2026 Nuvaxovid vaccine. Just make sure at least 2 months have passed since your last COVID vaccine.
If you have a weakened immune system, your healthcare professional can tell you how many doses you should get. They may want you to receive additional doses.
For more about COVID vaccines, see:
How to find a Novavax vaccine near me
You may be able to receive Nuvaxovid at a pharmacy in your neighborhood. Many pharmacies, including CVS, Walgreens, and Walmart, offer it. The same goes for several grocery stores and independent pharmacies. However, know that not every single location will keep in stock.
To find an updated Nuvaxovid vaccine near you, consider using Novavax’s official vaccine finder tool. You can either type in your ZIP code or allow the website to look at your location. If you aren't seeing any availability in your area, make sure to check back as supplies are updated.
Once you identify a pharmacy, it’s also a good idea to contact the pharmacy to double-check they actually have the updated Nuvaxovid vaccine in stock. A pharmacy’s inventory can routinely change.
While you’re on the phone, you can also ask the pharmacy staff if they accept walk-ins or if they prefer to stick to appointments. Different pharmacies have different policies.
The bottom line
The 2025-2026 Novavax COVID-19 vaccine, called Nuvaxovid, is FDA approved and recommended for adults and adolescents ages 12 and older. You can look for the Nuvaxovid vaccine at pharmacies near you by using an online search tool from the vaccine’s manufacturer. If you aren't sure which COVID vaccine you want to receive, ask a healthcare professional.
Why trust our experts?


References
Centers for Disease Control and Prevention. (2025). CDC immunization schedule adopts individual-based decision-making for COVID-19 and standalone vaccination for chickenpox in toddlers.
Centers for Disease Control and Prevention. (2025). Coronavirus disease 2019 (COVID-19) vaccine safety.
Centers for Disease Control and Prevention. (2025). COVID-19 vaccines.
Centers for Disease Control and Prevention. (2025). Interim clinical considerations for use of COVID-19 vaccines in the United States.
Centers for Disease Control and Prevention. (2025). Vaccines for moderately to severely immunocompromised people.
Novavax. (2025). Novavax's Nuvaxovid 2025-2026 formula COVID-19 vaccine approved in the U.S.
Novavax. (2025). Novavax [package insert].










